CSIMarket
 


Fibrogen Inc   (FGEN)
Other Ticker:  
 
 

FGEN's EPS Net Growth by Quarter and Year

Fibrogen Inc 's EPS Net results by quarter and year




FGEN EPS Net (in $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - -0.70 -1.44 0.35
III Quarter September -0.65 -0.98 0.54 -0.95
II Quarter June -0.90 -0.78 -1.45 -0.89
I Quarter March -0.81 -0.68 -0.78 -1.12
FY   -2.36 -3.14 -3.13 -2.61



FGEN EPS Net third quarter 2023 Y/Y Growth Comment
Fibrogen Inc in the third quarter 2023 recorded EPS net loss of $ -0.65 .

According to the results reported in the third quarter 2023, Fibrogen Inc achieved the best EPS Net growth in Major Pharmaceutical Preparations industry. While Fibrogen Inc ' s EPS Net no change of % ranks overall at the positon no. in the third quarter 2023.




FGEN EPS Net ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Fibrogen Inc 's third quarter 2023 EPS Net $ -0.65 FGEN's Income Statement
Fibrogen Inc 's third quarter 2022 EPS Net $ -0.98 Quarterly FGEN's Income Statement
New: More FGEN's historic EPS Net Growth >>


FGEN EPS Net (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS Net third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS Net third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS Net by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Fibrogen Inc 's Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


FGEN's III. Quarter Q/Q EPS Net Comment
Despite the fact, that Fibrogen Inc in the III. Quarter 2023 revealed EPS net loss of $ -0.65 , management point out, that current results are slight up side in contrast to the -0.90 in the second quarter.

Within Major Pharmaceutical Preparations industry Fibrogen Inc achieved highest sequential EPS Net growth. While Fibrogen Inc 's EPS Net growth quarter on quarter, overall rank is .


EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


FGEN's III. Quarter Q/Q EPS Net Comment
Although Fibrogen Inc in the III. Quarter 2023 admitted EPS net loss of $ -0.65 , some analyst point out, that those numbers point to improvement relative to the -0.90 in the second quarter.

Within Major Pharmaceutical Preparations industry Fibrogen Inc achieved highest sequential EPS Net growth. While Fibrogen Inc 's EPS Net growth quarter on quarter, overall rank is .


Fibrogen Inc 's 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative EPS Net 12 Months Ending $ -3.06 $ -3.39 $ -3.27 $ -3.14 $ -3.88
Y / Y EPS Net Growth (TTM) - - - - -
Year on Year EPS Net Growth Overall Ranking # # # # #
Seqeuential EPS Net Change (TTM) - - - - -
Seq. EPS Net Growth (TTM) Overall Ranking # # # # #




Cumulative EPS Net growth Comment


Fibrogen Inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS Net growth Comment


Fibrogen Inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS Net Growth
Major Pharmaceutical Preparations Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
FGEN's EPS Net Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for FGEN's Competitors
EPS Net Growth for Fibrogen Inc 's Suppliers
EPS Net Growth for FGEN's Customers

You may also want to know
FGEN's Annual Growth Rates FGEN's Profitability Ratios FGEN's Asset Turnover Ratio FGEN's Dividend Growth
FGEN's Roe FGEN's Valuation Ratios FGEN's Financial Strength Ratios FGEN's Dividend Payout Ratio
FGEN's Roa FGEN's Inventory Turnover Ratio FGEN's Growth Rates FGEN's Dividend Comparisons



Companies with similar EPS Net no change for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Sep 30 2023
National Research Corporation-3.03%$ -3.030 
Henry Schein Inc -3.67%$ -3.670 
Universal Health Services Inc -4.00%$ -4.000 
Mettler Toledo International Inc-5.64%$ -5.635 
The Pennant Group Inc -6.25%$ -6.250 
Corcept Therapeutics Inc-6.67%$ -6.667 
Viatris Inc -6.90%$ -6.897 
Quest Diagnostics Inc-9.68%$ -9.677 
Charles River Laboratories International inc -10.11%$ -10.106 
Stryker Corp-15.89%$ -15.888 
Zimmer Biomet Holdings Inc -16.30%$ -16.304 
Tenet Healthcare Corp-18.97%$ -18.966 
Amgen Inc -19.10%$ -19.095 
Zynex inc -23.08%$ -23.077 
Dariohealth Corp -23.44%$ -23.438 
Regeneron Pharmaceuticals Inc -23.76%$ -23.756 
Entera Bio Ltd -27.27%$ -27.273 
U S Physical Therapy Inc-29.17%$ -29.167 
Pediatrix Medical Group Inc -29.73%$ -29.730 
Avantor Inc -36.00%$ -36.000 
Ufp Technologies Inc -40.63%$ -40.625 
Biomx Inc -43.48%$ -43.478 
Laboratory Corporation Of America Holdings-45.90%$ -45.897 
Royalty Pharma Plc-50.00%$ -50.000 
Staar Surgical Company-52.38%$ -52.381 
Abbvie Inc -54.75%$ -54.751 
Repligen Corp-54.93%$ -54.930 
Envista Holdings Corporation-55.56%$ -55.556 
Oramed Pharmaceuticals Inc -55.56%$ -55.556 
Harmony Biosciences Holdings inc -56.25%$ -56.250 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com